Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2018-10-30 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
内部审计制度（2018年10月）
Governance Information Classification · 95% confidence The document is titled '内部审计制度' which translates to 'Internal Audit System' or 'Internal Audit Policy' of 华邦生命健康股份有限公司. It details the internal audit structure, responsibilities, procedures, and governance within the company. It is a policy or governance document related to internal audit functions, not a financial report, earnings release, or announcement. It does not contain financial statements or results, nor is it an announcement of a report publication. It is a governance-related document outlining internal audit rules and procedures, which fits best under Governance Information (CGR).
2018-10-30 Chinese
关于回购股份比例达2%的公告
Transaction in Own Shares Classification · 95% confidence The document is a public announcement from Huabang Life Health Co., Ltd. regarding the progress of its share repurchase program. It details the dates and amounts of shares repurchased, the percentage of total share capital repurchased (exceeding 2%), and references relevant stock exchange rules requiring disclosure when repurchase exceeds certain thresholds. The document is short (1092 characters) and focuses on reporting the share buyback activity rather than presenting financial statements or detailed analysis. This fits the definition of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back its own shares. There is no indication that this is a full financial report, regulatory filing, or announcement of a report publication. Therefore, the correct classification is POS with high confidence.
2018-10-17 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase activities. It details the number of shares repurchased, the price range, total amount paid, and references previous announcements about the share buyback plan. It does not contain financial statements or comprehensive financial data but is an update on the company's share repurchase program. According to the filing definitions, this fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back its own shares.
2018-10-08 Chinese
关于董事增持公司股份计划实施完成的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the completion of a director's share purchase plan. It details the director's name, the number of shares purchased, the amount spent, and compliance with relevant laws and regulations. There is no financial report, earnings data, or management discussion. The content fits the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives.
2018-09-28 Chinese
关于董事增持计划的公告
Director's Dealing Classification · 100% confidence The document is a public announcement from Huabang Life Health Co., Ltd. regarding a director's plan to increase their shareholding in the company. It details the director's intention to purchase shares, the source of funds, the method of purchase, and compliance with relevant laws and regulations. There is no financial report, earnings data, or management discussion. The content fits the definition of a Director's Dealing report, which involves personal share transactions by company directors. The document length is short and focused solely on the director's share purchase plan, confirming it is not a full financial report or other type of filing.
2018-09-03 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase activities. It details the number of shares repurchased, the price range, total amount paid, and references prior announcements and approvals related to the share buyback plan. It does not contain financial statements or detailed financial analysis but is an update on capital activity. According to the filing definitions, this fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back its own shares. The document length is short and focused solely on share repurchase progress, confirming it is not a full financial report or an announcement of a report publication.
2018-09-03 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.